Vontobel Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$443M Sell
718,886
-227,213
-24% -$127M 2.45% 16
2023
Q4
$527M Buy
946,099
+136,963
+17% +$66.3M 3.13% 12
2023
Q3
$436M Buy
809,136
+489,831
+153% +$261M 2.83% 14
2023
Q2
$174M Buy
319,305
+59,655
+23% +$32.2M 1.15% 31
2023
Q1
$158M Buy
259,650
+44,064
+20% +$24.8M 1.14% 32
2022
Q4
$126M Buy
215,586
+93,447
+77% +$49.5M 1% 32
2022
Q3
$66.3M Buy
+122,139
New +$68.4M 0.52% 40

Other funds holding TMO

Vontobel Asset Management's TMO Position: Q1 2024 in Review

Vontobel Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q1 2024, selling an estimated $127M and leaving 718,886 shares worth $443M. The position accounts for 2.45% of the portfolio, ranked #16.

Vontobel Asset Management first reported a position in TMO in Q3 2022 and has held it in 7 quarters since. The position peaked at $527M in Q4 2023. 2,534 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Vontobel Asset Management held 718,886 shares of Thermo Fisher Scientific worth $443M as of Q1 2024.
  • Vontobel Asset Management sold 227,213 Thermo Fisher Scientific shares in Q1 2024, an estimated $127M.
  • Thermo Fisher Scientific made up 2.45% of Vontobel Asset Management's portfolio in Q1 2024, its #16 holding.
  • Vontobel Asset Management first reported a position in Thermo Fisher Scientific in Q3 2022 and has held it in 7 quarters since.
  • Vontobel Asset Management's Thermo Fisher Scientific position peaked at $527M in Q4 2023.
  • 2,534 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Vontobel Asset Management's 13F filing for Q1 2024, filed 15 May 2024.